Literature DB >> 20490766

Identifying patterns of immune-related disease: use in disease prevention and management.

Rodney R Dietert1, Judith T Zelikoff.   

Abstract

BACKGROUND: Childhood susceptibility to diseases linked with immune dysfunction affects over a quarter of the pediatric population in some countries. While this alone is a significant health issue, the actual impact of immune-related diseases extends over a lifetime and involves additional secondary conditions. Some comorbidities are well known (e.g., allergic rhinitis and asthma). However, no systematic approach has been used to identify life-long patterns of immune-based disease where the primary condition arises in childhood. Such information is useful for both disease prevention and treatment approaches. DATA SOURCES: Recent primary research papers as well as review articles were obtained from PubMed, Chem Abstracts, Biosis and from the personal files of the authors. Search words used were: the diseases and conditions shown Figs. 1 and 2 in conjunction with comorbid, comorbidities, pediatric, childhood, adult, immune, immune dysfunction, allergy, autoimmune, inflammatory, infectious, health risks, environment, risk factors.
RESULTS: Childhood diseases such as asthma, type-1 diabetes, inflammatory bowel disease, respiratory infections /rhinitis, recurrent otitis media, pediatric celiac, juvenile arthritis and Kawasaki disease are examples of significant childhood health problems where immune dysfunction plays a significant role. Each of these pediatric diseases is associated with increased risk of several secondary conditions, many of which appear only later in life. To illustrate, four prototypes of immune-related disease patterns (i.e., allergy, autoimmunity, inflammation and infectious disease) are shown as tools for: 1) enhanced disease prevention; 2) improved management of immune-based pediatric diseases; and 3) better recognition of underlying pediatric immune dysfunction.
CONCLUSIONS: Identification of immune-related disease patterns beginning in childhood provides the framework for examining the underlying immune dysfunctions that can contribute to additional diseases in later life. Many pediatric diseases associated with dysfunctional immune responses have been linked with an elevated risk of other diseases or conditions as the child ages. Diseases within a pattern may be interlinked based on underlying immune dysfunctions and/or current therapeutic approaches for managing the entryway diseases. It may be beneficial to consider treatment options for the earliest presenting diseases that will concomitantly reduce the risk of immune-linked secondary conditions. Additionally, improved disease prevention is possible with more relevant and age-specific immune safety testing.

Entities:  

Mesh:

Year:  2010        PMID: 20490766     DOI: 10.1007/s12519-010-0026-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  86 in total

1.  Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation.

Authors:  Jonathan D Morrow; Mark R Opp
Journal:  Brain Behav Immun       Date:  2005-01       Impact factor: 7.217

Review 2.  The role of cytokines in sleep regulation.

Authors:  James M Krueger
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 3.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

4.  Altered neuroendocrine sleep architecture in patients with type 1 diabetes.

Authors:  Kamila Jauch-Chara; Sebastian M Schmid; Manfred Hallschmid; Jan Born; Bernd Schultes
Journal:  Diabetes Care       Date:  2008-02-25       Impact factor: 19.112

5.  Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients.

Authors:  G R Oliveira; B C V Teles; E F Brasil; M H L P Souza; L E T A Furtado; C M de Castro-Costa; F H Rola; L L B C Braga; F de A A Gondim
Journal:  Inflamm Bowel Dis       Date:  2008-03       Impact factor: 5.325

Review 6.  Cytokines and pathological sleep.

Authors:  Fotis Kapsimalis; Maria Basta; George Varouchakis; Konstantinos Gourgoulianis; Alexandros Vgontzas; Meir Kryger
Journal:  Sleep Med       Date:  2007-11-19       Impact factor: 3.492

7.  An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD.

Authors:  A Mustafa; S D Holladay; M Goff; S G Witonsky; R Kerr; C M Reilly; D P Sponenberg; R M Gogal
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-30       Impact factor: 4.219

8.  The managed immune system: protecting the womb to delay the tomb.

Authors:  Rodney R Dietert; Michael S Piepenbrink
Journal:  Hum Exp Toxicol       Date:  2008-02       Impact factor: 2.903

9.  Overweight, race, and psychological distress in children in the Childhood Asthma Management Program.

Authors:  Bruce G Bender; Anne Fuhlbrigge; Natalie Walders; Lening Zhang
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

Review 10.  Induction of asthma and the environment: what we know and need to know.

Authors:  MaryJane K Selgrade; Robert F Lemanske; M Ian Gilmour; Lucas M Neas; Marsha D W Ward; Paul K Henneberger; David N Weissman; Jane A Hoppin; Rodney R Dietert; Peter D Sly; Andrew M Geller; Paul L Enright; Gillian S Backus; Philip A Bromberg; Dori R Germolec; Karin B Yeatts
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

View more
  8 in total

1.  Pediatric diabetes registries: when baby steps are not enough.

Authors:  Chad Malone; Gary D Kennedy
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

2.  Prevalence of IgA antitissue transglutaminase antibodies in children with type 1 diabetes mellitus.

Authors:  Samaşca Gabriel; Iancu Mihaela; Butnariu Angela; Andreica Mariana; Dejica Doru
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Blood levels of lead and mercury and celiac disease seropositivity: the US National Health and Nutrition Examination Survey.

Authors:  Elena Kamycheva; Tadahiro Goto; Carlos A Camargo
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-09       Impact factor: 4.223

4.  Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease.

Authors:  Cynthia A Leifer; Rodney R Dietert
Journal:  Toxicol Environ Chem       Date:  2011       Impact factor: 1.437

Review 5.  Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.

Authors:  Rodney R Dietert; Jamie C DeWitt; Dori R Germolec; Judith T Zelikoff
Journal:  Environ Health Perspect       Date:  2010-05-18       Impact factor: 9.031

6.  Immunomodulatory effect of a formula developed from American ginseng and Chinese jujube extracts in mice.

Authors:  Zhuo-ping Yu; Dong-dong Xu; Lai-feng Lu; Xiao-dong Zheng; Wei Chen
Journal:  J Zhejiang Univ Sci B       Date:  2016-02       Impact factor: 3.066

7.  Hospitalisation with infection, asthma and allergy in Kawasaki disease patients and their families: genealogical analysis using linked population data.

Authors:  Rebecca J Webster; Kim W Carter; Nicole M Warrington; Angeline M Loh; Sophie Zaloumis; Taco W Kuijpers; Lyle J Palmer; David P Burgner
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

Review 8.  Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies.

Authors:  Rodney R Dietert
Journal:  Adv Med       Date:  2014-01-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.